
Cirodome 1mg Suspension
Marketer
Ciron Drugs & Pharmaceuticals Pvt Ltd
Salt Composition
Domperidone (1mg)
Overview Cirodome 1mg Suspension
PediaSolve 1mg Oral Suspension effectively manages indigestion, gastroesophageal reflux, nausea, and vomiting in pediatric patients. It accelerates gastric emptying, alleviating symptoms like bloating, satiety, and stomach upset. Administer PediaSolve 1mg Suspension optimally 30 minutes prior to meals. Post-meal administration remains effective, though absorption might be slightly reduced. Infants may receive a doctor-prescribed four times daily dosage, spaced at least four hours apart, ideally before each feeding. Dosage is individualized based on the child's age, weight, and condition. Do not prolong treatment beyond the prescribed period without consulting a physician. If vomiting occurs within 30 minutes, repeat the dose after the child has settled; however, avoid doubling the dose if the next scheduled dose is imminent. Minor, transient side effects such as dry mouth, headache, somnolence, abdominal cramping, and diarrhea may occur, typically resolving as the child adjusts. Persistent or troubling side effects warrant immediate medical attention. Inform your child's physician of any prior allergies, cardiac issues, hematological disorders, congenital anomalies, respiratory compromise, pulmonary abnormalities, gastrointestinal conditions, dermatological problems, hepatic impairment, or renal dysfunction. A complete medical history facilitates accurate dosing and treatment planning.
Uses of Cirodome 1mg Suspension
Managing gastroesophageal reflux disease (GERD) | Addressing indigestion | Relieving nausea | Treating vomiting
Major Benefits of Cirodome 1mg Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Consult the product label for detailed instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Cirodome 1mg Suspension should be consumed on an empty stomach.
Common Side effects of Cirodome 1mg Suspension:
- Dryness in mouth
- Headache
- Stomach cramp
- Diarrhea
- Drowsiness
How to use Cirodome 1mg Suspension:
Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Consult the product label for usage instructions prior to consumption. Utilize a measuring device for accurate oral administration. Ensure thorough shaking before each dose. Cirodome 1mg Suspension should be ingested on an empty stomach.
How Cirodome 1mg Suspension works:
Cirodome 1mg Suspension, a prokinetic agent, targets the brain's emetic center to suppress nausea and vomiting. Its action extends to the upper gastrointestinal tract, stimulating motility and facilitating the efficient passage of food through the stomach.
SAFETY ADVICE
KidneyCAUTION
Patients with severe kidney impairment should use Cirodome 1mg Suspension cautiously. Dosage modification of Cirodome 1mg Suspension might be necessary. Physician consultation is advised. Consistent monitoring of kidney function, especially during extended treatment, is recommended.
LiverCAUTION
Patients with liver impairment should use Cirodome 1mg Suspension cautiously, potentially requiring a modified dosage. Medical advice is recommended. Cirodome 1mg Suspension is unsuitable for children exhibiting severe hepatic dysfunction; pediatric consultation is necessary prior to administration.
What if you forget to take Cirodome 1mg Suspension :
If your child's physician hasn't prescribed an alternative, administer the missed dose immediately upon recollection. However, omit the dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate; instead, adhere to the recommended medication schedule.
Facts to Know About Cirodome 1mg Suspension
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Prokinetic agent with dopamine (D2) receptor antagonism |
